Webinar Explores Manufacturing Risks and Partner Strategies for the Next Five Years
The webinar titled "Manufacturing in Turbulent Times" is scheduled for September 17, 2026 and is designed to help biopharma sponsors understand the manufacturing challenges that lie ahead.
It notes that capacity constraints, geopolitical pressure, tighter regulatory scrutiny and fragmented technology are converging to create a volatile environment for drug production.
Sponsors and contract manufacturing organizations are encouraged to strengthen partnerships, and the session will offer a practical framework and checklist for selecting CDMOs or CMOs that can endure these pressures.
Attendees will learn how to avoid common pitfalls such as process‑transfer gaps and compliance blind spots, and will gain insight into the traits of future‑ready manufacturing partners.
This writeup was produced by pharmadog from original reporting by BioSpace.
Original headline: “Webinar: Manufacturing in Turbulent Times”
read at BioSpace ↗
comments(0)
5-min edit window · permanent after that